机构地区:[1]广西医科大学第一附属医院耳鼻咽喉头颈外科,南宁530021 [2]钦州市第二人民医院耳鼻咽喉头颈外科
出 处:《临床耳鼻咽喉头颈外科杂志》2017年第20期1593-1598,共6页Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基 金:国家自然科学基金(No:81560174;81360157);广西自然科学基金(No:2014GXNSFAA118137);2017广西研究生教育创新计划项目(No:YCSW2017103)
摘 要:目的:观察水杨酸钠(SS)对大鼠耳蜗螺旋神经节神经元(SGN)的多巴胺受体(DR)亚型表达的影响,以及观察SS作用下,DR对SGN的N-甲基-D-天冬氨酸(NMDA)受体和γ-氨基丁酸(GABA)a受体亚单位的影响,探讨SS介导的受体之间的相互作用。方法:应用免疫荧光技术,检测新生SD大鼠SGN中DR两家族DR1、DR2的表达;应用RT-PCR技术,检测SS处理后的SGN中DR1和DR2亚型的mRNA变化,观察在激活和抑制DR活动时SS对SGN的NMDA受体亚单位NR1、GABAa受体亚单位GABRα2的mRNA表达的影响。结果:免疫荧光显示:在SGN的胞体与突起均有DR1、DR2的免疫荧光显示。RT-PCR结果显示:(1)SGN有DR亚型(DRd1~DRd5)、GABRα2、NR1的表达;(2)5mmol/L SS作用SGN 30min后,除DRd3外,其余DR亚型及GABRα2、NR1的mRNA表达量均明显升高,其中DRd1表达增加34.64%(t=-5.123,P=0.007);DRd2表达增加34.60%(t=-5.206,P=0.006);DRd4表达增加20.87%(t=-3.337,P=0.029);DRd5表达增加26.42%(t=-6.054,P=0.004);GABRα2表达增加30.41%(t=-2.839,P=0.047);NR1表达增加39.22%(t=-6.243,P=0.003);(3)SS分别与多巴胺(100μmol/L)、DR1激动剂(SKF38393,20μmol/L)、DR2激动剂(Quinpirole,20μmol/L)分别作用SGN 30min后,GABRα2、NR1的mRNA表达量均明显升高,其中,GABRα2表达分别增加21.78%、27.45%、33.02%、33.42%(F=12.399,P=0.001),NR1表达分别增加28.70%、26.82%、29.03%、35.05%(F=50.395,P=0.000);(4)SS+DR1拮抗剂(SCH23390,20μmol/L)、SS+DR2拮抗剂(Eticlopride,20μmol/L)分别作用SGN 30min后,与单独SS作用相比,GABRα2的mRNA表达分别减少29.56%、37.10%(F=22.101,P=0.000),NR1的mRNA表达分别减少37.62%、32.83%(F=72.933,P=0.000)。结论:SS可诱导SGN的大部分DR亚型的mRNA表达明显升高;SS可能通过DR影响SGN上GABAaR、NMDAR的mRNA表达。Objective:To investigate mRNA expression of dopamine receptor subtypes in the rat cochlear spi- ral ganglion neurons (SGN) following exposure to the sodium salicylate. In addition, we observed the effect of so- dium salicylate on N methyl -D- aspartic acid (NMDA) receptor subunit NR1 and gamma aminobutyric acid (GA- BA)a receptor subunit GABRa2 mRNA under the circumstance of DR activation or blocking. Moreover, we also focused on the the interaction between receptors mediated by SS. Method.: Immunofluorescence techniques were ap- plied to detect DR (DR1 and DR2) expression in cultured rat SGN. Moreover, RT-PCR was performed to assess NR1 and GABRα2 subunit mRNA. Result: Immunofluorescence images showed co-localization of DR1/DR2 and β Ⅲ-tubulin protein in SGN bodies and axons. RT-PCR results illustrated that ①DR subtypes of DRdl- 5 were detected in the SGN. @The mRNA expression of all subtypes of DR and GABRa2, NR1 subunits were obviously upregulated except DRd3 after treatment with sodium salicylate. Among them, DRdl expression increased 34.64% (t=-5. 123, P= 0. 007), DRd2 expression increased 34.60% (t=-5. 206, P= 0. 006), DRd4 expression increased 20.87 % (t=-3. 337, P=0. 029), DRd5 expression increased 26.42 % (t= -6. 054, P= 0.004), GABRa2 expression increased 30.41% (t= -2. 839, P=0. 047), NR1 expression increased 39.22% (t= -6. 243, P=0. 003). @After exposure to sodium salicylate (5 mmol/L), dopamine (100μmol/L), DR1 agonist (SKF38393, 20μmol/L), DR2 ago- nist (Quinpirole, 20μmol/L), GABRa2 expression increased 21.78%, 27.45%, 33.02%, 33.42% respectively (F=12.399, P= 0.001), and NR1 expression increased 28.70%, 26.82%, 29.03%, 35.05% (F=50. 395, P=0. 000) respectively. @Compared with the group of sodium salicylate treatment alone, both sodium salicylate + DR1 an- tagonist (SCH23390, 20μmol/L) group and sodium salicylate -l- DR2 antagonists (Eticlopride, 20 μmol/L) group had a suppression on GABRa2 and NR1 mRNA expre
关 键 词:水杨酸钠 耳蜗螺旋神经节神经元 多巴胺受体 N-甲基-D-天冬氨酸受体 A型γ-氨基丁酸受体
分 类 号:R764.35[医药卫生—耳鼻咽喉科]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...